SignatureFD’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $576K | Sell |
1,063
-46
| -4% | -$23.8K | 0.01% | 637 |
|
|
2026
Q2 | $601K | Buy |
1,109
+131
| +13% | +$73.8K | 0.01% | 589 |
|
|
2026
Q1 | $580K | Buy |
978
+82
| +9% | +$40.8K | 0.01% | 553 |
|
|
2025
Q4 | $437K | Buy |
896
+35
| +4% | +$16.3K | 0.01% | 653 |
|
|
2025
Q3 | $361K | Buy |
861
+251
| +41% | +$84.4K | 0.01% | 703 |
|
|
2025
Q2 | $175K | Buy |
610
+14
| +2% | +$4.18K | ﹤0.01% | 978 |
|
|
2025
Q1 | $184K | Sell |
596
-67
| -10% | -$23K | ﹤0.01% | 923 |
|
|
2024
Q4 | $234K | Buy |
663
+30
| +5% | +$11K | ﹤0.01% | 797 |
|
|
2024
Q3 | $227K | Buy |
633
+51
| +9% | +$17.2K | ﹤0.01% | 811 |
|
|
2024
Q2 | $185K | Buy |
582
+109
| +23% | +$28.8K | ﹤0.01% | 846 |
|
|
2024
Q1 | $109K | Buy |
473
+64
| +16% | +$14.4K | ﹤0.01% | 1135 |
|
|
2023
Q4 | $89.9K | Buy |
409
+15
| +4% | +$3.46K | ﹤0.01% | 1160 |
|
|
2023
Q3 | $89K | Buy |
394
+20
| +5% | +$4.61K | ﹤0.01% | 1117 |
|
|
2023
Q2 | $82.6K | Sell |
374
-36
| -9% | -$7.97K | ﹤0.01% | 1160 |
|
|
2023
Q1 | $91.8K | Buy |
410
+69
| +20% | +$17K | ﹤0.01% | 1084 |
|
|
2022
Q4 | $94.8K | Sell |
341
-31
| -8% | -$7.83K | ﹤0.01% | 1032 |
|
|
2022
Q3 | $78K | Buy |
372
+5
| +1% | +$1.12K | ﹤0.01% | 1085 |
|
|
2022
Q2 | $86K | Buy |
367
+9
| +3% | +$1.83K | ﹤0.01% | 1051 |
|
|
2022
Q1 | $64K | Sell |
358
-67
| -16% | -$12.8K | ﹤0.01% | 1250 |
|
|
2021
Q4 | $92K | Buy |
425
+40
| +10% | +$7.85K | ﹤0.01% | 1060 |
|
|
2021
Q3 | $71K | Buy |
385
+16
| +4% | +$3.15K | ﹤0.01% | 1133 |
|
|
2021
Q2 | $66K | Buy |
369
+7
| +2% | +$1.33K | ﹤0.01% | 1143 |
|
|
2021
Q1 | $61K | Buy |
362
+54
| +18% | +$9K | ﹤0.01% | 1092 |
|
|
2020
Q4 | $47K | Buy |
308
+108
| +54% | +$14.2K | ﹤0.01% | 1113 |
|
|
2020
Q3 | $20K | Sell |
200
-121
| -38% | -$13.3K | ﹤0.01% | 1381 |
|
|
2020
Q2 | $39K | Buy |
321
+187
| +140% | +$21K | ﹤0.01% | 1059 |
|
|
2020
Q1 | $13K | Buy |
134
+25
| +23% | +$2.38K | ﹤0.01% | 1401 |
|
|
2019
Q4 | $10K | Buy |
109
+32
| +42% | +$2.82K | ﹤0.01% | 1477 |
|
|
2019
Q3 | $6K | Buy |
77
+1
| +1% | +$81 | ﹤0.01% | 1581 |
|
|
2019
Q2 | $6K | Sell |
76
-722
| -90% | -$67.5K | ﹤0.01% | 1550 |
|
|
2019
Q1 | $94K | Buy |
798
+236
| +42% | +$27.5K | 0.01% | 655 |
|
|
2018
Q4 | $61K | Sell |
562
-490
| -47% | -$56.8K | 0.01% | 762 |
|
|
2018
Q3 | $135K | Buy |
1,052
+243
| +30% | +$30.1K | 0.01% | 534 |
|
|
2018
Q2 | $92K | Buy |
809
+70
| +9% | +$7.69K | 0.01% | 640 |
|
|
2018
Q1 | $83K | Buy |
+739
| New | +$93.9K | 0.01% | 598 |
|
|
2016
Q4 | – | Sell |
-226
| Closed | -$27K | – | 1177 |
|
|
2016
Q3 | $27K | Buy |
226
+192
| +565% | +$23.1K | ﹤0.01% | 716 |
|
|
2016
Q2 | $4K | Sell |
34
-82
| -71% | -$9.15K | ﹤0.01% | 1136 |
|
|
2016
Q1 | $13K | Buy |
116
+93
| +404% | +$11.8K | ﹤0.01% | 779 |
|
|
2015
Q4 | $4K | Sell |
23
-45
| -66% | -$6.55K | ﹤0.01% | 963 |
|
|
2015
Q3 | $9K | Buy |
68
+61
| +871% | +$9.8K | ﹤0.01% | 702 |
|
|
2015
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 1007 |
|
|
2015
Q1 | $1K | Sell |
7
-2
| -22% | -$305 | ﹤0.01% | 913 |
|
|
2014
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 821 |
|
|
2014
Q3 | $1K | Sell |
9
-70
| -89% | -$7.22K | ﹤0.01% | 667 |
|
|
2014
Q2 | $7K | Buy |
79
+70
| +778% | +$6.73K | ﹤0.01% | 534 |
|
|
2014
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 735 |
|
|
2013
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 678 |
|
|
2013
Q3 | $1K | Buy |
+9
| New | +$658 | ﹤0.01% | 620 |
|
Other funds holding UTHR
SignatureFD's UTHR Position: Q3 2026 in Review
SignatureFD reduced its United Therapeutics (UTHR) stake by 4.1% in Q3 2026, selling an estimated $23.8K and leaving 1,063 shares worth $576K. The position accounts for 0.01% of the portfolio, ranked #637.
SignatureFD first reported a position in UTHR in Q3 2013 and has held it in 48 quarters since. The position peaked at $601K in Q2 2026. 165 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- SignatureFD held 1,063 shares of United Therapeutics worth $576K as of Q3 2026.
- SignatureFD sold 46 United Therapeutics shares in Q3 2026, an estimated $23.8K.
- United Therapeutics made up 0.01% of SignatureFD's portfolio in Q3 2026, its #637 holding.
- SignatureFD first reported a position in United Therapeutics in Q3 2013 and has held it in 48 quarters since.
- SignatureFD's United Therapeutics position peaked at $601K in Q2 2026.
- 165 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.